The company will emphasize what it says is the first and only organic version of the probiotic yeast Saccharomyces boulardii.
Lallemand Health Solutions (Toulouse, France) will share its probiotic portfolio at the Vitafoods Europe trade show taking place in Geneva, Switzerland, on May 9-12 (Booth F40).
Among other ingredients, the company will highlight what it’s positioned as the first and only organic version of the probiotic yeast Saccharomyces boulardii. Women’s health is also a focus, and the company says it offers many probiotic solutions that can address a women’s lifespan, from puberty to menopause.
Finally, the firm will highlight its probiotic solutions for mental health, such as its documented probiotic strain L. rhamnosus HA-114, which has shown benefits for eating behaviors, mental health, metabolic profile, and for overweight individuals.
The company will also unveil new delivery innovations for probiotics, including a mint-flavored dissolvable lozenge aimed at the oral health market. It can include any of the company’s probiotic ingredients for oral health that address teeth, gum, and breath health. The company will also share results from a new in vitro study on halitosis.
Finally, the firm will share its probiotics for food and beverage applications, including spore-forming bacteria and microencapsulated lactobacilli and bifidobacterium strains.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.